EF

E for L Aim Public Company Limited

EFORL · BK · Healthcare / Medical Distribution

0.11THB+0.01 (+10.00%)

Price History

Full chart

Market Stats

Previous Close0.10
Open0.11
Day Range0.10 – 0.12
52-Week Range0.10 – 0.18
Volume14.89M
Market Cap399.85M
P/E (TTM)10.00
Forward P/E14.51
EPS0.01
Dividend Yield0.00%
Beta-0.07
50-Day Avg0.1136
200-Day Avg0.1295

About

E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia. The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, as well as ICU, transport, and MRI ventilators, anesthesia delivery system, incubator and radiant warmer, phototherapy, spirometer, pulmonary function lab, and cardiopulmonary exercise testing devices. It also provides handheld and ultrasound scanners, high flow oxygen therapy, ceiling pendant, hemodialysis machine, continuous renal replacement therapy, ozone hybrid, patients and medical devices tracking system, MRI infusion and monitor systems, MRI ferrous metal detector, video laryngoscope, hydrogen peroxide plasma sterilizing, and picture archiving and communication devices, as well as clean rooms, anesthesia record system, ECG viewer system, CIS for hemodialysis, telemedicine, telehealth, and PM and after-sale services. In addition, the company offers diagnosis and laboratory products, such as clinical chemistry, hematology, and immunoassay systems, blood gas and banking, urinalysis, hemoglobin A1C analyzer, automated immunoassay analyzer, rapid test kit, coagulation, POCT clinical chemistry analyzers, air purifier, and laboratory information system. Further, it distributes microscopes for life sciences comprising educational microscopes, clinical and laboratory microscopes, and microscopes for biological scientific research. The company was formerly known as Absolute Impact Public Company Limited and changed its name to E for L Aim Public Company Limited in September 2013. E for L Aim Public Company Limited was incorporated in 2005 and is based in Bangkok, Thailand.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Preecha Nuntnarumit
  • Employees0
  • Headquarters432, Rajhaviti Road, Bangkok, Thailand, 10700, Thailand
  • Websitehttps://www.eforl-aim.com

Leadership

  • Mr. Preecha NuntnarumitCEO, Acting CFO, MD & Director · b. 1959
  • Mr. Jackrit LohajaroensubExecutive Director · b. 1961
  • Ms. Sunanta MerabiebAccounting Manager
  • Ms. Chonticha PumpruekHead of Compliance Unit & Investor Relations
  • Mr. Supachai PrukmathakulExecutive Director and Assistant MD of Medical Sales & Marketing
  • Mr. Thanongsak PraditthanHead of Internal Audit
  • Ms. Mattana JulnilCompany Secretary

Financials

Income Statement

Currency: THB2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue135.76M220.33M199.63M155.38M192.59M87.20M170.76M1.45B4.50B3.67B2.47B2.06B1.92B1.67B2.17B1.49B1.31B1.34B1.31B
Growth (%)-+62.29%-9.39%-22.17%+23.95%-54.72%+95.82%+749.27%+210.56%-18.46%-32.64%-16.72%-6.73%-13.25%+29.90%-31.07%-12.24%+2.30%-2.57%
Cost of Revenue63.34M107.58M159.67M177.95M167.97M76.19M103.58M942.71M3.21B2.98B2.03B1.43B1.34B1.13B1.44B996.75M869.75M891.78M865.64M
Gross Profit72.42M112.74M39.95M-22.58M24.62M11.02M67.19M507.54M1.29B693.23M445.43M629.11M580.11M538.12M727.12M495.73M440.09M448.23M439.93M
Gross Margin53.35%51.17%20.01%-14.53%12.78%12.63%39.35%35.00%28.67%18.88%18.01%30.54%30.19%32.28%33.58%33.22%33.60%33.45%33.70%
Operating Expense41.30M58.78M90.94M101.19M74.02M75.28M38.94M220.41M940.75M993.79M825.22M684.12M682.59M493.99M446.44M401.92M403.19M392.33M381.13M
Operating Income31.12M53.96M-50.99M-123.77M-49.40M-64.27M28.25M287.13M350.66M-300.56M-379.80M-55.01M-102.48M44.13M280.68M93.82M36.90M55.90M58.80M
Operating Margin22.92%24.49%-25.54%-79.66%-25.65%-73.70%16.54%19.80%7.79%-8.18%-15.35%-2.67%-5.33%2.65%12.96%6.29%2.82%4.17%4.50%
EBITDA65.18M102.47M35.50M-20.27M7.56M-19.88M46.49M335.90M843.28M-868.10M-1.98B-109.34M-463.42M-572.38M341.03M140.00M91.15M108.58M110.33M
EBITDA Margin48.01%46.51%17.78%-13.05%3.92%-22.80%27.22%23.16%18.72%-23.64%-79.89%-5.31%-24.12%-34.34%15.75%9.38%6.96%8.10%8.45%
Net Income23.37M49.44M-54.96M-124.51M-51.26M-65.43M26.46M240.73M210.39M-614.45M-1.16B-166.31M-590.58M-633.52M812.03M53.04M13.43M19.69M44.57M
Net Income Margin17.21%22.44%-27.53%-80.13%-26.61%-75.03%15.49%16.60%4.67%-16.73%-47.02%-8.07%-30.74%-38.01%37.50%3.55%1.03%1.47%3.41%
Interest Expense5.35M3.05M3.87M2.43M3.52M1.16M75.00K18.69M240.44M183.88M170.33M134.19M82.37M72.81M48.90M29.51M31.10M33.13M27.86M
Interest Expense % of Total Revenue3.94%1.38%1.94%1.57%1.83%1.33%0.04%1.29%5.34%5.01%6.89%6.51%4.29%4.37%2.26%1.98%2.37%2.47%2.13%

Balance Sheet

Currency: THB2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets238.68M314.47M313.14M191.26M160.42M60.86M840.99M7.37B7.31B6.75B3.89B3.22B2.44B1.56B1.68B1.54B1.37B1.41B1.25B
Total Liabilities72.15M48.51M39.93M42.56M63.68M29.54M143.22M5.42B4.31B4.76B3.98B2.94B2.55B2.30B1.28B1.04B843.71M861.78M669.63M
Total Equity166.53M265.97M273.21M148.70M96.75M31.32M697.78M938.50M1.31B962.76M131.41M442.46M324.14M734.04M392.89M506.42M524.62M544.31M583.26M
Cash12.03M45.30M26.98M17.36M37.10M9.49M641.26M339.44M122.46M558.21M62.87M79.12M34.39M15.44M134.35M144.26M40.58M82.24M23.64M
Total Debt31.08M-24.41M15.11M39.76M754.00K528.00K3.45B2.65B3.03B1.99B1.59B1.30B1.04B783.02M574.57M468.68M376.38M300.73M
Net Debt19.04M-45.30M-2.58M-2.26M2.66M-8.74M-640.74M3.11B2.53B2.47B1.93B1.52B1.27B1.02B648.67M430.30M428.10M294.15M277.09M

Cash Flow

Currency: THB2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow53.78M58.40M28.43M19.44M7.28M74.19M246.00K-122.60M74.95M-484.70M408.69M-128.19M34.98M315.66M-52.97M223.60M39.32M164.90M115.15M
Investing Cash Flow-77.61M-39.73M-98.01M-16.75M-8.45M-731.00K-4.44M-3.65B865.90M-2.90M-167.51M-34.99M-44.78M-3.04M-101.06M-58.68M-27.50M-24.54M-90.29M
Financing Cash Flow30.89M14.60M51.26M-12.32M20.91M-35.64M635.96M3.47B-1.16B923.35M338.59M179.44M-34.93M-331.56M273.39M-155.01M-115.50M-98.70M-81.90M
Capital Expenditure72.61M24.73M109.90M20.02M8.73M2.33M2.11M21.34M142.69M82.97M156.40M22.82M52.83M22.56M28.46M16.16M40.19M30.18M17.53M
Free Cash Flow-18.82M33.67M-81.48M-572.00K-1.46M71.86M-1.86M-143.94M-67.74M-567.67M252.28M-151.01M-17.85M293.10M-81.43M207.44M-863.00K134.72M97.62M
Dividends Paid--19.60M---92.00M92.00M92.00M186.75M0--------
FCF to OCF-35.00%57.65%-286.62%-2.94%-20.00%96.86%-756.50%117.41%-90.39%117.12%61.73%117.80%-51.03%92.85%153.72%92.77%-2.19%81.70%84.77%
Dividend Paid to FCF---24.06%----4943.42%-63.91%-135.80%-32.90%0.00%--------

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 8, 2014Nov 6, 2014Mar 5, 2015Jun 3, 2015Aug 11, 2015Nov 11, 2015Mar 1, 2016May 16, 2016Aug 15, 2016Feb 28, 2017May 12, 2017Aug 15, 2017Nov 14, 2017Mar 20, 2018May 11, 2018Aug 15, 2018Nov 14, 2018Mar 7, 2019May 10, 2019Aug 12, 2019Nov 27, 2019Feb 26, 2020May 15, 2020Aug 17, 2020Dec 2, 2020Mar 3, 2021May 14, 2021Aug 16, 2021Dec 1, 2021Feb 28, 2022May 13, 2022Aug 15, 2022Nov 14, 2022Feb 24, 2023May 12, 2023Aug 10, 2023Nov 10, 2023Feb 28, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Feb 21, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.10---0.100.300.10-----------------------------------------
EPS Actual0.020.02-0.05-0.12-0.04-0.04-0.01-0.07-0.00-0.010.010.020.350.030.060.040.080.020.030.04-0.02-0.05-0.35-0.03-0.04-0.02-0.640.06-0.000.00-0.08-0.00-0.01-0.00-0.07-0.120.010.020.010.010.020.170.010.000.000.000.00-0.010.000.000.00-0.01-0.010.010.01-0.000.000.010.000.000.00
Surprise--------------70.00%----80.00%-90.00%-60.00%-----------------------------------------
Timing-------------After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketAfter-hoursAfter-hours--After-hoursAfter-hours------------------------------

Key Statistics & Ratios

Market Cap399.85M
Enterprise Value732.81M
Trailing P/E10.00
Forward P/E14.51
Price / Sales0.34
Price / Book0.81
EPS0.01
Book Value0.148
Revenue (TTM)1.17B
Gross Profit (TTM)419.38M
EBITDA95.57M
Profit Margin3.62%
Operating Margin5.20%
Return on Equity7.36%
Return on Assets3.17%
Shares Outstanding4.00B
Shares Float3.22B
Beta-0.07
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20161×
0.20May 4, 2016
20151×
0.10Apr 27, 2015
20091×
0.05Apr 3, 2009

Stock Splits

  • Apr 21, 20221:10
  • Jun 20, 201367:48
  • Aug 28, 200910:1